We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Enzo Challenges Bioequivalence Standard

Law360 (December 19, 2006, 12:00 AM EST) -- Enzo Pharmaceutical Holdings Inc. has urged U.S. regulators not to rely on a newly proposed standard for determining whether proposed generic substitutes for Endo’s Lidoderm topical pain patch meet the requirements...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.